Radiopharmaceuticals
Radioactive isotopes used in medical imaging, radiation therapy, and brachytherapy.
Diagnostic Imaging
Most widely used diagnostic isotope. Bone scans, myocardial perfusion imaging, renal function studies. Emits 140 keV gamma rays ideal for gamma camera detection.
Fluorine (Z=9)
PET scanning with fluorodeoxyglucose (FDG). Cancer detection and staging, brain imaging for Alzheimer's, cardiac viability assessment.
Thyroid imaging and uptake studies. Preferred over I-131 for diagnostic imaging due to lower radiation dose and better image quality.
Infection and inflammation imaging. Tumor imaging for lymphoma and hepatocellular carcinoma. Accumulates in areas of rapid cell division.
Therapeutic (Radiation Therapy)
Thyroid cancer ablation and treatment of hyperthyroidism. Selectively concentrated by thyroid tissue via the sodium-iodide symporter.
External beam radiation therapy. Gamma Knife stereotactic radiosurgery for brain tumors. Produces two gamma rays at 1.17 and 1.33 MeV.
Treatment of bone metastases from castration-resistant prostate cancer (Xofigo). Alpha particles provide high linear energy transfer with short range.
Peptide receptor radionuclide therapy for neuroendocrine tumors (Lutathera). Prostate cancer therapy (PSMA-targeted). Dual beta/gamma emission allows therapy and imaging.
Brachytherapy
High-dose-rate brachytherapy for cervical, head and neck, breast, and lung cancers. Versatile energy spectrum suitable for many treatment sites.
Low-dose-rate brachytherapy for cervical cancer. Blood product irradiation to prevent transfusion-associated graft-versus-host disease.